Article Details

AstraZeneca Cuts Innate-Partnered Phase 3 Trial In Head & Neck Cancer - Benzinga

Retrieved on: 2022-08-01 19:21:18

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Cuts Innate-Partnered Phase 3 Trial In Head & Neck Cancer - Benzinga. View article details on hiswai:

Excerpt

Monalizumab is being studied in a Phase 3 study sponsored by AstraZeneca, evaluating durvalumab in combination with monalizumab or AstraZeneca's ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up